Holen Sie sich die Stockscreener-App
21.97
3.93%
0.83
Handel nachbörslich:
21.99
0.02
+0.09%
Schlusskurs vom Vortag:
$21.14
Offen:
$21.41
24-Stunden-Volumen:
2.12M
Relative Volume:
1.28
Marktkapitalisierung:
$1.40B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-107.85M
KGV:
-9.9412
EPS:
-2.21
Netto-Cashflow:
$-106.82M
1W Leistung:
+14.13%
1M Leistung:
-7.77%
6M Leistung:
-35.72%
1J Leistung:
-42.11%
1-Tages-Spanne:
$21.26
$22.74
1-Wochen-Bereich:
$19.07
$22.74
52-Wochen-Spanne:
$18.53
$51.61
Vera Therapeutics Inc Stock (VERA) Company Profile
Firmenname
Vera Therapeutics Inc
Sektor
Branche
Telefon
650-770-0077
Adresse
2000 SIERRA POINT PARKWAY, SUITE 1200, BRISBANE
Vergleichen Sie VERA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VERA
Vera Therapeutics Inc
|
21.97 | 1.35B | 0 | -107.85M | -106.82M | -2.21 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Vera Therapeutics Inc Stock (VERA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-04 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2025-05-05 | Fortgesetzt | H.C. Wainwright | Buy |
| 2025-02-04 | Eingeleitet | Wolfe Research | Outperform |
| 2025-01-28 | Eingeleitet | Goldman | Buy |
| 2024-11-21 | Eingeleitet | Wells Fargo | Overweight |
| 2024-10-16 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-01-25 | Eingeleitet | Oppenheimer | Outperform |
| 2024-01-08 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-12-18 | Eingeleitet | Raymond James | Outperform |
| 2023-11-10 | Hochstufung | Jefferies | Hold → Buy |
| 2023-08-16 | Eingeleitet | Guggenheim | Buy |
| 2023-01-04 | Herabstufung | Jefferies | Buy → Hold |
| 2023-01-04 | Herabstufung | Wedbush | Outperform → Neutral |
| 2022-07-12 | Eingeleitet | JP Morgan | Overweight |
| 2022-05-02 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-04-19 | Eingeleitet | Wedbush | Outperform |
Alle ansehen
Vera Therapeutics Inc Aktie (VERA) Neueste Nachrichten
Is Vera Therapeutics Inc. stock a hidden gemSmart Portfolio Allocation - thegnnews.com
Vera Therapeutics (NASDAQ:VERA) Price Target Cut to $53.00 by Analysts at JPMorgan Chase & Co. - MarketBeat
What makes Vera Therapeutics Inc. stock price move sharplyFree Portfolio Health Check - thegnnews.com
Custom watchlist performance reports with Vera Therapeutics Inc.Portfolio Safety Metrics and Return Analysis - Newser
HC Wainwright Analysts Lower Earnings Estimates for VERA - Defense World
Cantor Fitzgerald Issues Negative Forecast for VERA Earnings - Defense World
Vera Therapeutics, Inc. (NASDAQ:VERA) Given Consensus Recommendation of “Moderate Buy” by Analysts - Defense World
J.P. Morgan Maintains Vera Therapeutics(VERA.US) With Buy Rating, Cuts Target Price to $53 - 富途牛牛
Vera Therapeutics Inc. stock daily chart insightsTrade Ideas Based on Fundamental Metrics - Newser
Vera Therapeutics: Equity Incentives and BLA Timelines Signal Confidence in Value Creation - AInvest
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Vera Therapeutics Awards Major Stock Package: 99,000 Options, 48,200 RSUs to Expand Team - Stock Titan
Will Vera Therapeutics Inc. Stock Benefit from AI and Green Energy TrendsFree Trend Analysis for Safer Trades - Newser
Wedbush Research Analysts Reduce Earnings Estimates for VERA - Defense World
Vera Therapeutics (VERA) to Release Quarterly Earnings on Thursday - Defense World
Can volume confirm reversal in Vera Therapeutics Inc.Free Capital Growth With Controlled Risk Picks - Newser
Vera Therapeutics Advances Clinical Trials and Financials Amid Progress Toward Commercial Launch - AInvest
Vera Therapeutics Q2 Net Loss Doubles, Revenue at $76.5 Million - AInvest
Vera (VERA) Q2 Net Loss Widens 127% - The Motley Fool
Vera Therapeutics Reports Progress in Clinical Trials - TipRanks
A Quick Look at Today's Ratings for Vera Therapeutics(VERA.US), With a Forecast Between $60 to $85 - 富途牛牛
Bkv Corporation shares rise 1.82% after-hours following Vera Therapeutics' positive trial results and upcoming BLA submission. - AInvest
Vera Therapeutics Signs New Sales Agreement with TD Securities - TipRanks
Vera Therapeutics files for offering of up to $200 million Class A Common Stockfiling - MarketScreener
Form 424B5 Vera Therapeutics, Inc. - StreetInsider
Vera Therapeutics sees cash funding operations through launch of atacicept - TipRanks
Vera Therapeutics reports Q2 EPS ($1.20), consensus (62c) - TipRanks
Vera Therapeutics announces anticipated upcoming milestones - TipRanks
Vera Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results - The Manila Times
Trendlines Converge — Decision Point for Vera Therapeutics Inc.Momentum Based Equity Trading Plans Reviewed - metal.it
Vera Therapeutics Shares Fall After Downgrade From Wolfe Research - MarketScreener
Wolfe Research downgrades Vera Therapeutics stock rating on limited catalysts - Investing.com Canada
This AvalonBay Communities Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Monday - Benzinga
Vera Therapeutics downgraded to Peer Perform from Outperform at Wolfe Research - TipRanks
Vera Therapeutics Inc.’s Price Action Aligns with Quant SignalsFast Exit and Entry Strategy Guide Offered - metal.it
How volatile is Vera Therapeutics Inc. stock compared to the marketAchieve breakthrough financial results today - Jammu Links News
Is Vera Therapeutics Inc. a growth stock or a value stockBuild wealth faster with expert stock selection - Jammu Links News
Is Vera Therapeutics Inc. a good long term investmentAchieve breakthrough profits with expert advice - Jammu Links News
How strong is Vera Therapeutics Inc. company’s balance sheetPowerful profit generation - Jammu Links News
What are the latest earnings results for Vera Therapeutics Inc.Breakthrough wealth creation - Jammu Links News
Vera Therapeutics Inc. Stock Analysis and ForecastAchieve breakthrough performance with smart picks - Jammu Links News
What is the dividend policy of Vera Therapeutics Inc. stockBuild your wealth with consistent stock growth - Jammu Links News
What catalysts could drive Vera Therapeutics Inc. stock higher in 2025Discover breakthrough stocks before the crowd - Jammu Links News
What are Vera Therapeutics Inc. company’s key revenue driversStay ahead with daily expert stock picks - Jammu Links News
Does Vera Therapeutics Inc. stock perform well during market downturnsUnlock exclusive trading strategies - Jammu Links News
What is Vera Therapeutics Inc. company’s growth strategyFree Real-Time Stock Data - Jammu Links News
What are the technical indicators suggesting about Vera Therapeutics Inc.Free Buy/Sell Signal Notifications - Jammu Links News
Short Interest Drops in Vera Therapeutics Inc. After RallyCommunity Strategy With High Win Rate Backtested - metal.it
Top Risks to Consider Before Buying Vera Therapeutics Inc. StockHigh Conviction Intraday Stock Signals Detected - metal.it
Vera Therapeutics shares fall 2.21% intraday as Alnylam Pharmaceuticals reports strong Q2 2025 results. - AInvest
Published on: 2025-07-30 16:01:27 - metal.it
Finanzdaten der Vera Therapeutics Inc-Aktie (VERA)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):